Q: Magazine Issue 3 Sept. 2020 | Page 10

COVID-19 NEWS A Biobank for the Lifespan Q: Why doesn’t SARS-CoV-2 affect kids the same way it affects adults? It’s been a relief for parents and pediatric specialists alike that children, as a group, don’t seem to get as sick as adults do from COVID-19. It’s also an urgent research question: Why don’t they? “There might be factors in children that protect them,” says pediatric pulmonologist and critical care specialist Peter Mourani, MD. “Alternately, there could be factors in adults that make them more vulnerable. And there are kids who do get very sick, and we want to understand why that happens, while other kids are protected.” COVID-19 RESEARCH, ALL TOGETHER Back in April, Thomas Flaig, MD, was thinking about those questions, too. As Vice Chancellor for Research at the University of Colorado Denver and Anschutz Medical Campus, home to Children’s Colorado and the University of Colorado School of Medicine, he knew he’d be fielding a lot of requests for COVID-19 data and specimens. “We had all these research groups planning to do individual biobanks,” he says. “We said, let’s do a campuslevel protocol, put them all together and support research that covers the entire lifespan.” The resulting campus-wide biobank collects COVID-19+ tissues from consenting pediatric and adult patients, harvesting specimens from testing and blood from labs into a shared repository that syncs tissue samples up with electronic health record data. That would be crucial — to align the samples with the clinical data to better understand correlations between anomalies and outcomes. But it’s difficult, too, because different institutions keep electronic health records differently. Combining the data in a meaningful, reliable way requires special expertise. Luckily, the Anschutz Medical Campus had that infrastructure in place in the form of Health Data Compass, an existing campus resource set up to leverage electronic health record data for crossinstitutional collaborations exactly like this one. And in this case, it would support dozens of different research projects. BIOBANKING THE DATA “So for example, my group is interested in extracting RNA from respiratory specimens to understand how characteristics of the SARS- CoV-2 virus, the respiratory tract microbiome, and host gene expression interact to impact disease severity 10 | CHILDREN’S HOSPITAL COLORADO